Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInchcape Regulatory News (INCH)

Share Price Information for Inchcape (INCH)

Share Price is delayed by 15 minutes
Get Live Data
815.00    2.50 (0.31%)
Bid:
814.50
Ask:
815.50
Spread: 1.00 (0.123%)
Market Cap: £2.86b
INCH Live PriceLast checked at - London Stock Exchange

Intraday Inchcape Share Chart

Share repurchase programme

28 Feb 2022 08:31

RNS Number : 0039D
Inchcape PLC
28 February 2022
 

Inchcape plc - Share repurchase programme

Inchcape plc (the Company) announces that, as part of the new £100 million buyback programme set out in its preliminary results for the year to 31 December 2021 published on 24 February 2022, it is commencing a share buyback programme (the Initial Programme) to purchase shares with a value of up to £50 million (inclusive of applicable taxes, fees and costs) during the period starting on 28 February 2022 and ending no later than 27 July 2022, the sole purpose of which is to reduce the capital of the Company

The Company has entered into an agreement with EXANE SA (BNP Paribas EXANE) under which it has issued an instruction to BNP Paribas EXANE to manage the Initial Programme. BNP Paribas EXANE will carry out its instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the UKLA Listing Rules and the provisions of the retained version of the Market Abuse Regulation 596/2014/EU as applicable in the United Kingdom pursuant to section 3 of the European Union (Withdrawal) Act 2018 and will be conducted in accordance with such general authority conferred by the Company's shareholders to repurchase the shares in place from time to time (at the Annual General Meeting in 2021, shareholders gave the Company authority to purchase a maximum of 39,327,439 ordinary shares and, taking into account purchases by the Company since that date, the maximum number of shares which the Company may purchase pursuant to that authority is 27,715,307).

Ends

Inchcape plc - Investor RelationsRaghav Gupta-Chaudhary +44 (0)7933 395 158, investors@inchcape.com

InstinctifTim McCall +44 (0)20 7457 2020, inchcape@instinctif.com

About InchcapeInchcape is the leading independent multi-brand global automotive distributor, operating in over 40 markets and territories with a portfolio of the world's leading automotive brands. Inchcape has diversified multi-channel revenue streams including sale of new and used vehicles, parts, service, finance and insurance. The Company has been listed on the London Stock Exchange (INCH) since 1958, and is classified within the 'Business Support Services' sector. The Group is headquartered in London and employs around 14,500 people globally. www.inchcape.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAPAPAASAEEA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20268:45 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20265:19 pmRNSDirector/PDMR Shareholding
27th May 20269:07 amRNS-RInchcape publishes 2025 Sustainability Report
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSInchcape agrees to acquire Silver Star in Bulgaria
18th May 20262:52 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20261:02 pmRNSResult of AGM
11th May 20267:00 amRNSTransaction in Own Shares
7th May 20261:34 pmRNSDirector/PDMR Shareholding
5th May 20263:53 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSTransaction in Own Shares
30th Apr 202610:32 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSQ1 2026 Trading Update
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 202610:14 amRNSDirector/PDMR Shareholding
14th Apr 20265:05 pmRNSDirector/PDMR Shareholding
13th Apr 20262:41 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20264:51 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20262:15 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20264:38 pmRNSHolding(s) in Company
24th Mar 202610:05 amRNS2025 Annual Report and 2026 AGM Notice
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20263:18 pmRNSDirectorate change
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSNew £175m share buyback programme
3rd Mar 20267:00 amRNSFinal Results
27th Feb 202610:57 amRNSTotal Voting Rights
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20264:04 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.